Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,647 | 7,995 | 9,771 | 6,631 | 640 |
| Depreciation Amortization | 5,503 | 4,049 | 2,638 | 1,204 | 4,190 |
| Accounts payable and accrued liabilities | 187 | 220 | 121 | -349 | 185 |
| Other Working Capital | -5,562 | -9,961 | -9,145 | -9,070 | 3,900 |
| Other Operating Activity | -187 | -220 | -121 | 349 | -2,095 |
| Operating Cash Flow | $2,588 | $2,083 | $3,264 | $-1,235 | $6,820 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -307,598 | -289,126 | -289,126 | -217,159 | -114,821 |
| PPE Investments | -8,716 | -4,546 | -2,796 | -1,327 | -3,350 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-316,314 | $-293,672 | $-291,922 | $-218,486 | $-118,170 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 150,000 |
| Debt Repayment | -400 | -296 | -197 | -99 | -369 |
| Common Stock Issued | 12,853 | 6,762 | 5,376 | 1,406 | 366,121 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2 |
| Financing Cash Flow | $12,453 | $6,466 | $5,179 | $1,307 | $515,750 |
| Beginning Cash Position | 421,541 | 421,541 | 421,541 | 421,541 | 17,130 |
| End Cash Position | 120,268 | 136,418 | 138,062 | 203,127 | 421,540 |
| Net Cash Flow | $-301,273 | $-285,123 | $-283,479 | $-218,414 | $404,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,588 | 2,083 | 3,264 | -1,235 | 6,820 |
| Capital Expenditure | -8,716 | -4,546 | -2,796 | -1,327 | -3,355 |
| Free Cash Flow | -6,128 | -2,463 | 468 | -2,562 | 3,465 |